Skin injury induces the formation of new blood vessels by activating the vasculature in order to restore tissue homeostasis. Vascular cells may also differentiate into matrix-secreting contractile myofibroblasts to promote wound closure. Here, we characterize a PECAM1 + /Sca1 + vascular cell population in mouse skin, which is highly enriched in wounds at the peak of neoangiogenesis and myofibroblast formation. These cells express endothelial and perivascular markers and present the receptor CD38 on their surface. PECAM1 
Abstract
Skin injury induces the formation of new blood vessels by activating the vasculature in order to restore tissue homeostasis. Vascular cells may also differentiate into matrix-secreting contractile myofibroblasts to promote wound closure. Here, we characterize a PECAM1 + /Sca1 + vascular cell population in mouse skin, which is highly enriched in wounds at the peak of neoangiogenesis and myofibroblast formation. These cells express endothelial and perivascular markers and present the receptor CD38 on their surface. PECAM1
+ cells proliferate upon wounding and could give rise to a-SMA + myofibroblast-like cells. CD38 stimulation in immunodeficient mice reduced the wound size at the peak of neoangiogenesis and myofibroblast formation. In humans a corresponding cell population was identified, which was enriched in sprouting vessels of basal cell carcinoma biopsies. The results indicate that PECAM1 + /Sca1 + /CD38 + vascular cells could proliferate and differentiate into myofibroblast-like cells in wound repair. Moreover, CD38 signaling modulates PECAM1 + /Sca1 + /CD38 + cell activation in the healing process implying CD38 as a target for anti-angiogenic therapies in human basal cell carcinoma.
Introduction
The interaction of fibroblasts and vascular cells with the microenvironment is crucial to restore tissue integrity in skin wound healing. Resident fibroblasts are activated upon tissue injury to repopulate the wounded area and reconstruct the connective tissue. Therefore, fibroblasts undergo significant phenotypic changes into migrating and extracellular matrixsecreting myofibroblasts. Changes in the wound environment also initiate an angiogenic response during wound repair. Lining endothelial and perivascular cells migrate into the wound and form a new vascular bed to facilitate an adequate oxygen and nutrient supply. Both cell types may also transform into myofibroblast-like cells to promote non-vessel tissue repair [1] . Previous experiments indicated that PECAM1 + endothelial cells can adapt a myofibroblast-like phenotype by forming a-smooth muscle actin (a-SMA)-containing stress fibers in corneal wounds [2] and give rise to fibroblast-like cells [3] . Perivascular cells (PVCs) are assumed to be activated during skin wound healing to migrate to the perivascular space and transform into myofibroblast-like cells [4, 5] . Moreover, PVCs display mesenchymal stem cell-like properties [6, 7] and are thought to contribute to the fibrotic reactions in spinal cord scar tissue formation [8] . Hence, endothelial cells and perivascular cells could represent a source for mesenchymal cells upon tissue repair [9, 10] . Sca1 is often used to identify subpopulation of endothelial progenitor cells in the bone marrow or in the circulation [11, 12] . We have previously detected Sca1 at the cell surface of a perivascular cell population in the vasculature of adult brain meninges [7, 13] that can differentiate into various mesenchymal cell types.
In this work, we have used the expression of Sca1 and PECAM1 to analyze the contribution of the vasculature to myofibroblast formation and wound repair in the skin [9, 10] . We identified a vascular PECAM1
+ cell subpopulation, which was highly enriched in the granulation tissue of skin wounds and in neoangiogenic areas of human basal cell carcinoma. Surprisingly, cells expressed perivascular cell-specific genes like Desmin, Pdgfrb and Angp1 and the endothelial cell-specific genes Angpt2 and Tie2. In addition, the PECAM1 receptor CD38 was found exclusively in PECAM1 
/CD38
+ Vascular Cells moreover imply CD38 as a target for anti-angiogenic therapy of human basal cell carcinoma.
Materials and Methods

Ethics Statement, Mice, Biopsies
Animal experiments were performed with C57BL/6N or C.129S6(B6)-Rag2tm1FwaN12 mice on BALB/c background in accordance with the animal ethics guidelines of the German law. Institutional review board: ''Landesamt für Natur, Umwelt-und Verbraucherschutz NRW'', (ethic approval no. 31.08.261, 20.11.057). Human foreskin samples and basal cell carcinoma biopsies were provided by the SFB829-core facilities. Institutional review board:'' Ethik-Kommission der Medizinischen Fakultä t der Universitä t zu Köln'' (Ethic approval no. 08-144). Written informed consent was obtained from the patients.
Histology and Immunohistochemistry
Cryosections were used for histological and immunohistochemical analysis. For morphological assessment sections were stained for nuclei (hematoxylin) and cytoplasm (eosin) according to standard procedures. For immunofluorescence studies monoclonal rat anti-CD31 (BD), mouse anti-a-SMA (Sigma), mouse antidesmin (Progen), rat anti-Sca1 (BD), rat anti-CD38 (Biolegend), rat anti-Tie2 (BD), rat anti-CD34 (BD) antibodies were used on paraformaldehyde-fixed sections. Corresponding secondary antibodies coupled to Alexa Fluor 488 (Molecular Probes) or Cy3 (Jackson Immuno Research) and DAPI (Invitrogen) were applied. Images were taken and analyzed by immunofluorescence (Nikon Eclipse TE2000-U Microscope) and confocal microscopy (LeicaTCS-SP5).
Wound Healing Experiments
Mice were anesthetized by i.p. injection of Ketavet/Rompun (Bayer) and full thickness wounds of 6 mm diameter were inflicted at the back. For antibody treatments 75 mg/150 ml of rat anti-CD38 or isotype control antibody (SouthernBiotech) were injected on day two, four and six post wounding into the retro-orbital venous sinus. Wounds were embedded in tissue tek (Sakura Finetek) and serial sections from the central portion of the wound (Leica Cryotome, CM3050) were stained with hematoxylin and eosin (H&E). Morphometric parameters [14] were determined using ImageJ software [15] .
Fluorescence Activated Cell Sorting and Cell Culture
Isolated skin or wounds were digested with 0.5% (w/v) DispaseH II (Roche) in PBS at 4uC overnight. Subcutaneous tissue and epidermis were removed, dermis incubated in 0.2% (w/v) collagenase type 1 (Worthington) in DMEM-F12, 10% FCS for 1 K h at 37uC, washed with 5% FCS/PBS and passed through a 40 mm cell strainer (BD). ,6610 5 cells were recovered from skin or wound of a mouse. Cells were incubated for 15 min on ice in 5% FCS/PBS with mouse-Fc-Block (BD), and then stained for 15 min on ice with primary conjugated monoclonal antibodies specific for CD31, CD34, CD38, CD45, Sca1 or Tie2. Cells were washed, costained with 7-actinomycin (7AAD) followed by flow cytometry (FACSCantoII, BD) or cell sorting (FACSAriaIII, BD). To detect intracellular a-SMA, cells were fixed and permeabilized in IntraSure solution (BD) prior staining. For cell cycle analysis cells were labeled with antibodies, fixed and permeabilized in IntraSure solution (BD) and costained with propidium iodide (BD). Cells were analyzed by flow cytometry. The Watson algorithm [16] of the Flow Jo software (Tree Star, Inc) was used for data processing. For cell culture experiments 5000 sorted cells were cultured in VascuLife SMC medium (LifeLine Technology) containing 5 ng/ml FGF, EGF, insulin, 50 ng/ml ascorbic acid and 5% FCS at 37uC with 5% CO 2 .
Semiquantitative RT-PCR
RNA from sorted cells was isolated using NucleoSpin-RNA-XS Kit (Macherey&Nagel) and quality was assessed by capillary electrophoresis according to the manufacturer's specifications (Agilent2100Bioanalyzer). RNA samples were reversely transcribed into cDNA using the SuperscriptIII 1u-strand Synthesis Kit (Invitrogen). Semiquantitative RT-PCRs were performed for Desmin, Pdgfrb, Angpt1, Angpt2, Tie2, Pecam1, Sca1, CD34, CD38 and Gapdh according to standard procedures and band intensities of the electrophoretic gels were processed and quantified using Image J software [15] . Primer sequences will be provided on request.
Results
The Vasculature is Reorganized During Skin Repair
To study the distribution of the vasculature in skin repair, wounds were inflicted at the back of eight weeks old C57BL/6N mice ( Fig. 1A ) and vascular marker expression was analyzed. In the early phase of inflammation hardly any PECAM1
+ endothelial or desmin + perivascular cells were seen in the wound ( (Fig. 1C ). Stem cell antigen 1 (Sca1), known to be expressed in isolated perivascular cells from brain meninges [13] , was hardly detected in the wound at one day post injury (Fig. 1D) To define the origin of Sca1
+ cells we analyzed cell suspensions from dermis and wounds at various times points using flow cytometry. Cells were stained for 7AAD and the cell surface markers CD45, Sca1 and PECAM1. In the newborn dermis Sca1 + cells represented 7.5% of the 7AAD -viable CD45 -nonhematopoietic cell population, which increased to 43% and 49% in the juvenile and adult dermis, respectively ( Fig. 2A , n$10 mice). Approximately 1% of the newborn and up to 6.2% of the juvenile and adult dermal cells expressed PECAM1. In addition, 0.8% of the cells in newborn dermis and 2.3% in the juvenile and adult dermis expressed both proteins. In wounds no significant changes were seen for Sca1 + cells at the analyzed time points, whereas the proportion of PECAM1 + cells decreased from 5.6% in the unwounded control to 0.5% within the first three days after tissue injury ( + /Sca1 + cells were enriched at the peak of neoangiogenesis, matrix secretion and myofibroblast appearance. The expression profile of sorted Sca1 + , PECAM1 + and PECAM1
+ /Sca1 + cell populations from dermis and wounds seven days post injury were assayed by semiquantitative PCR to define the origin of PECAM1
+ cells (Fig. 3A) . + cells. Similar expression profiles were seen in wound-derived cell populations. Flow cytometry confirmed the presence of TIE2, CD34 and CD38 proteins on the cell surface of the distinct cell populations (Fig. 3B) 
/Sca1
+ cells in the wound. We therefore studied the localization of CD38 + cells in the maturing skin and wounds by immunofluorescence analysis (Fig. 4) . In newborn skin no signal for CD38 was seen, although PECAM1
+ vessels were present throughout the dermis. In contrast, in skin at three weeks and three months a strong signal for CD38 was detected in a subpopulation of PECAM1 + vessels of the reticular dermis (Fig. 4A, B) . In the early phase of the healing progress (D1) only a few CD38
+ cells were present in the wound (Fig. 4C) 
+ /CD38 + cells were found in the S-phase and 8% in the G2 phase of the cell cycle (Fig. 5A, Fig. S1 ). Hence, only PECAM1 + /Sca1 + /CD38 + cells proliferate upon wounding at the peak of myofibroblast appearance. In addition, cells of skin and wounds were analyzed for a-SMA expression by flow cytometry analysis. In unwounded skin single PECAM1
+ or PECAM1 + /Sca1 + /CD38 + cells lack the expression a-SMA (Fig. S2C ). This is in line with the immunofluorescence analysis of a-SMA expression in the newborn, 3 weeks and 3 months old skin, where a-SMA could only be found in the glassy membrane of the hair follicles and in the arrector pili muscle muscle tissue, but was nearly absent in the vasculature of the dermis (Fig. S2A) . In the wound a-SMA was detected in 17% of Sca1 + cells and 4.5% of PECAM1 + /Sca1 + cells (Fig. 5B) , whereas PECAM1
+ cells lack the expression of a-SMA. In parallel sorted cells were cultured for five days on glass under conditions of mechanical tension and then assessed by immunofluorescence analysis for a-SMA expression. The presence of numerous intact DAPI + nuclei indicated that most cells of the Sca1
+ or PECAM1 + cell population survived the isolation procedure (Fig. 5C) + cells can differentiate into a-SMA + myofibroblast-like cells. To determine the function of CD38 for this differentiation process in vivo we triggered the CD38 receptor activity by intravenous injection of a CD38 antibody into wounded mice (n = 4). In order to avoid stimulatory effects of the injected antibody on CD38
+ lymphoid B-and T-cells, Rag2-deficient mice were used, which have no mature B-or T-cells [18] . Four wounds were inflicted on the back of the mice and the healing progress was studied seven days post injury. Wounds were isolated, sectioned and stained with hematoxylin and eosin (H&E). Morphometric assessment showed a significant reduction in wound size for anti-CD38 antibody-treated mice (Fig. 5D) . The distances between the edges of the panniculus carnosus and the hair follicles were shortened by 20% and 25%, respectively, and the granulation tissue was reduced by 21%. These data indicate that CD38 receptor signaling in PECAM1 + /Sca1 + cells promotes vesselderived myofibroblast formation to support the healing progress.
PECAM1
+ /CD38 + Vascular Cells can be Identified in Human Foreskin and in Vascular Sprouts of Basal Cell Carcinomas
To identify a human orthologue vascular cell population we determined the distribution of CD38, PECAM1 and a-SMA by immunofluorescence analysis of human foreskin sections (Fig. 6A) .
Sca1 was not considered for analysis due to the lack of a human orthologue. PECAM1
+ endothelial cells were detected throughout the foreskin, whereas only a subpopulation of PECAM1 + vessels expressed the CD34 or CD38 receptors. Flow cytometry analysis demonstrated that 1.1% of the viable non-hematopoietic cell population represent PECAM1 +
/CD38
+ cells and within this population 92% of the cells expressed CD34. Approximately 2% of the PECAM1 + /CD38 + cells contained a-SMA protein as shown by intracellular a-SMA staining (Fig. 6B) . In a subsequent semiquantitative PCR study genes preferentially expressed in perivascular cells like DESMIN, PDGFRB and ANGPT1 were detected in sorted CD38
+ cells, whereas endothelial cell-specific genes like ANGPT2 and TIE2 were mainly found in sorted PECAM1
+ cells (Fig. 6C) . Both perivascular and endothelial cellspecific genes were expressed in sorted PECAM1
+ cells. Hence, a human counterpart for the murine PECAM1 + /Sca1
+ cell population was identified. The vasculature may contribute to fibrotic tissue formation and pathological neoangiogenesis in humans. Therefore, the distribution of CD38 was studied on cryosections of biopsies from fibrotic scleroderma and neovascularised human basal cell carcinoma (BCC) patients. In four biopsies from patients with late fibrosis no signal for CD38 was detected in immunofluorescent analysis. In contrast, five out of seven BCC biopsies showed a staining for CD38 (Fig. S3) . To define CD38
+ cells sections of two biopsies were costained with antibodies detecting PECAM1, CD38 and a-SMA and analyzed by confocal microscopy. A high density of vessels with strong PECAM1 expression (PECAM1 high ) was found throughout the stroma of the first analyzed biopsy (Fig. 7B) . CD38
+ cells were detected only in areas of low PECAM1 expression (PECAM1 low ) in the outermost PECAM1 + cell layer of sprouting vessels. CD38-expressing cells also originated from a dilated vessel to form a PECAM low /CD38 + loop-like structure (Fig. 7C) + cells was seen in the second tumor within a vascular outgrowth from a pre-existing small vessel. CD38 expression was detected in the PECAM1 low cells at the vascular tip (Fig. 7D, arrowheads) , which seemed to migrate towards the nearby vessel to form a vascular bridge. In summary, CD38
+ cells are found in neoangiogenic PECAM1 low areas of the stromal vasculature in BCC biopsies.
Discussion
Sca1 and PECAM1 expression is commonly used to identify vascular progenitor cells in various tissues and previous studies suggested that tissue-resident Sca1 + [11, 19] or PECAM1 20] precursor cells may exist in the microvasculature to promote neoangiogenesis and tissue repair. In this study PECAM1 and Sca1 expression were used to define the vascular cell populations that are activated during skin repair. The detection of both markers showed that non-hematopoietic Sca1 + and PECAM1 + /Sca1 + are present in the dermis of the skin. Sca1
+ cells expressed perivascular cell-specific marker genes such as Pdgfrb and Desmin, but some of the perivascular cell-specific genes may also be expressed by fibroblasts [5] . In contrast, a low proportion of PECAM1
+ cells is found in the skin, which was transiently enriched in the granulation tissue of wounds seven days post injury coinciding temporally with neoangiogenesis and myofibroblast formation. These cells are capable of responding to environmental changes in the wound to enter the cell cycle upon injury and express endothelial and perivascular cell-specific genes as well as the progenitor cell marker CD34. The concomitant
+ Vascular Cells expression of endothelial and perivascular cell-specific genes may suggest that endothelial cells transiently undergo endothelial-tomesenchyme transition in the vasculature of wounded skin. It is remarkable that all cells within the PECAM1 + /Sca1 + population express CD34 and CD38, whereas PECAM1 + or Sca1 + cells fail to do so. Therefore, the purified cells represent a homogeneous population in a unique localization within the vasculature of the skin. CD34 expression has been reported for bone marrow-derived circulating endothelial progenitors [21] . PECAM1
+ cells may originate from these CD34 + bone marrowderived precursors but the lack of the hematopoietic CD45 marker expression renders this scenario rather unlikely.
In order to promote non-vessel tissue repair PECAM1
+ cells have to transform into mesenchymal cells. Myofibroblast-like cells in the intervascular stroma of wounds seven days post injury appear to emerge from pre-existing PECAM1
+ vessels (see Fig. 1D and Fig. S2B ). Mechanical challenge is an important trigger to induce myofibroblast formation from a variety of progenitors [1] and gain of a-SMA expression is a hallmark of this differentiation process. We detected intracellular a-SMA in 4% of the wound-derived PECAM1 + /Sca1 + /CD38 + cells, which form extended a-SMA containing stress fibres in vitro, whereas PECAM1 + single positive cells fail to do. Moreover, in cell suspensions from intact skin no intracellular a-SMA was detected in these cell populations. Therefore, it is likely that a proportion of PECAM1 + /Sca1 + /CD38 + cells can undergo significant phenotypic changes upon wounding to transform into migrating, proliferating and matrix-secreting myofibroblast-like cells to contribute to the pool of myofibroblasts as it was previously described for endothelial cells in cardiac fibrosis [3] .
In order to get activated PECAM1 + /Sca1 + /CD38 + cells need to react to changes in the local environment. CD38 can interact with hyaluronan of the extracellular matrix [22] , which is upregulated in skin wounds of mice. Elevated levels of hyaluronan are associated with faster closure, increased tensile strength, and less dermal scarring [23] . We showed that CD38 expression is restricted to the cell surface of PECAM1 +
/Sca1
+ /CD38 + cells in the intact and repairing skin. PECAM1
+
/Sca1
+ /CD38 + cells in the vasculature may therefore sense changes in the extracellular hyaluronan concentration via the CD38 receptor to become activated.
When stimulating the CD38 receptor by injection of CD38 antibody [24] a pronounced effect on wound healing progression was seen. In these mice the size of the wound was reduced by 20% and although the deposited antibodies hampered the analysis of the distribution of the vasculature we speculate that the stimulation of the PECAM1
+ cell population via the CD38 receptor caused this size reduction. First, CD38 expression is exclusively expressed by PECAM1 +
+ /CD38 + cells throughout the healing process (see Fig. 4 ) and second, effects of anti-CD38 antibodies on CD38 + T-or B-cells can be excluded due to the usage of Rag2 2/2 mice, which fail to produce mature B-or Tlymphocytes [18] . Hence, PECAM1
+ /Sca1 + /CD38 + cells are the most likely target for the crosslinking CD38 antibodies in wounds. Therefore, the reduced wound size could be caused by the altered activation of the CD38 receptor on PECAM1 + /Sca1 + cells, which is accompanied by changes in neoangiogenesis or myofibroblast formation. Interestingly, in human basal cell carcinoma (BCC) PECAM1 low /CD38 + cells are mainly found in the highly vascularized tumor stroma in regions of newly formed vascular sprouts, whereas most of the mature PECAM1 high vessels lack CD38 expression. The availability of monoclonal CD38 antibodies [25] and the rather restricted expression upon pathological neoangiogenesis in the human BCCs makes the CD38 receptor also an attractive immunotherapeutic target to prevent new vessel formation and thereby tumor growth. Figure S1 Characterization of the cell proliferation in skin and wound. Cell cycle analysis of skin-and wound-derived Sca1 
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